Preferences help
enabled [disable] Abstract
Number of results
2005 | 54 | 2-3 | 213-220
Article title

Rak pęcherza moczowego - molekularne podłoże genezy i leczenia

Title variants
Bladder cancer - molecular basis of genesis and therapy
Languages of publication
Bladder cancer is one of the most common human tumours.This malignancy develops in various tissues of the bladder. The disease is caused by several factors e.g. some chemical agents and radiation. Ingredients of smoke and numerous industrial chemicals play a role in cancer cells formation. Aromatic amines and some their derivatives introduce changes in DNA sequences. Mutations of some suppressor genes and protooncogenes (p53, Rb) may contribute to tumour transformation. Mitomycin C, adriamycin and other chemiotherapeutics destroy cancer cells acting on plasma membrane and mitochondrial apoptotic pathways. This review article presents the molecular basis of formation and of the mechanisms of urinary bladder.
Physical description
  • Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im. L. Rydygiera w Bydgoszczy Katedra i Zakład Histologii i Embriologii, Karłowicza 24, 85-092 Bydgoszcz, Polska
  • Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im. L. Rydygiera w Bydgoszczy Katedra i Zakład Histologii i Embriologii, Karłowicza 24, 85-092 Bydgoszcz, Polska
  • Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im. L. Rydygiera w Bydgoszczy Katedra i Zakład Histologii i Embriologii, Karłowicza 24, 85-092 Bydgoszcz, Polska
  • ACEHAN D., JIANG X., MORGAN D. G., HAUSER J. E., WANG X., AKEY CH.W., 2002. Three- dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding and activation. Mol. Cell 9, 423-432.
  • BORNER C., 2003. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39, 615-647.
  • BORKOWSKI A. Rak pęcherza. On-line.
  • CAIN K., BRATTON S. B., COHEN G. M., 2002. The Apaf1 apoptosome: a large caspase-activating complex. Biochimie 84, 203-214.
  • CHANG F. L., LAI M. D., 2001.Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells. J Urol. 166, 304-310.
  • CHANG F. L., LAI M. D., 2000. The relationship between p53 status and anticancer drugs-induced apoptosis in nine human bladder cancer cell lines. Anticancer Res. 20, 351-355.
  • CHANG F. L., LING Y. F., LAI M. D., 2000. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells. Anticancer Res. 20, 329-336.
  • CHAU B. N., CHENG E. H., KERR D. A., HARDWICK J. M., 2000. Aven, a novel inhibitor of caspase activation, binds Bcl-XL and Apaf-1. Mol. Cell 6, 31-40.
  • DUGGAN B. D., KELLY J. D., KEANE P. F., JOHNSON S. R., WILLIAMSON K. E., 2001. Molecular targets for the therapeutic manipulation of apoptosis in bladder cancer. J. Urol. 165, 946-995.
  • FU W. F., BERTONI F., KELSEY S. M., MCELWAINE S. M., COTTER F. E., NEWLAND A.C., JIA L., 2003. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene 22, 451-455.
  • GIANNOPOULOU I., NAKOPOULOU L., ZERVAS A., LAZARIS A. C., STRAVODIMOS C., GIANNOPOULOS A., DAVARIS P. S., 2002. Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications. Urol. Res. 30, 342-345.
  • GOMEZ-NAVARRO J, CURIEL D. T., DOUGLAS J. T., 1999. Gene therapy for cancer. Eur J Cancer 35, 2039-2057.
  • JUNG I., MESSING E., 2000. Molecular mechanisms and pathway in bladder cancer development and progressino. Cancer Control 7, 325-334.
  • KAWASAKI T., TOMITA Y., BILIM TOMISTA., TAKEDA M., TAKAHASHI K., KUMANISHI T., 1996. Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/ WAF1/CIP1 and/or p53 gene alterations. Int. J Cancer 15, 501-505.
  • KELLY J. D., WILLIAMSON K. E, WEIR H. P., MCMANUS D. T., HAMILTON P. W., KEANE P. F., JOHNSTON S. R., 2000. Induction of apoptosis by mitomycin-C in an ex vivo model of bladder cancer. Br J Urol. 85, 911-917.
  • KŁYSZEJKO-STEFANOWICZ L. 2002. Cytobiochemia. PWN Warszawa
  • KWIATKOWSKA D., KWIATKOWSKA-KORCZAK J., 2000. Heterodimeryczne receptory jądrowe. Receptory witamin i hormonów. Post. Bioch. 46, 115-124.
  • LIU J., WANG Q., WANG X., SUN Y., CHEN X., KONG Q., ZHANG K., LI H., 2003 . Apoptosis of bladder cancer cells induced by short-term and low-dose Mi-tomycin-C: Potential molecular mechanism and clinical implication. Mol. Med. 11, 389-394.
  • LORENZO-ROMERO J. G., SALINAS-SANCHEZ A. S., GIMENEZ-BACHS J. M., SANCHEZ-SANCHEZ F., ESCRIBANO-MARTINEZ J., SEGURA-MARTIN M., HERNANDEZ-MILLAN I. R., VISEDA-RODRIGUES J. A., 2003. Prognostic implications of p53 gene mutations in bladder tumors. J Urol. 169, 492-499.
  • LOTAN R., DAWSON M. I., ZOU C. C., JONG L., LOTAN D., ZOU C. P., 1995. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha- interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 55, 232-236.
  • LOTAN R., TRIZNA Z., ZOU C. C., LOTAN D., MITCHELL M. F., ZOU C. P., 1996. Additive inhibition effects of retinoids and interferon-alpha on the growth of human cervical carcinoma cells: Lack of association with HPV status or retinoid receptor expression. Int. J Oncol. 8, 5-13.
  • MANTEUFFEL-CYMBOROWSKA M., 1999. Nuclear receptors, their coactivators and modulation of transcription. Acta Biochim. Polon. 46, 77-89.
  • MILECKI P., KWIAS Z., NAWROCKI S., SKACEL T., SKONECZNA I., 2002. Leczenie raka pęcherza moczowego: stan obecny i perspektywy. Współ. Onkol, 6, 465-472.
  • MIZUTANI Y., YOSHIDA O., BONAVIDA B., 1998. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplati-num (II). J Urol. 160, 561-570.
  • MIZUTANI Y., YOSHIDA O., MIKI T., BONAVIDA B., 1999. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells. Clin Cancer Res. 9, 2605-2612.
  • MIZUTANI Y., HONGO F., SATO N., OGAWA O., YOSHIDA O., MIKI T., 2001. Significance of serum soluble fas ligand in patients with bladder carcinoma.
  • Cancer 92, 287-293.
  • MRÓZ P., MŁYNARCZYK I., 2000. Mechanizmy indukcji apoptozy i zastosowanie TRAIL w terapii nowotworów. Post. Biol. Kom. 30, 113-128.
  • OHNO H., 2000. Effects of testosterone on cell proliferation and apoptosis in BNN- induced mouse urinary bladder cancer. Yon. Acta Med. 43, 121-130.
  • ROZENFELD-GRANOT G., KRISHNAMURTHY J., KANNAN K., TOREN A., AMARIGLION., GIVOL D., RECHAVI G., 2002. A positive feedback mechanism in the transcription activation of Apaf-1 by p53 and the coactivator Zac-1. Oncogene 21, 1469-1476.
  • SHIMIZU S., NARITA M., TSUJIMOTO Y., 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.
  • SKIPPER P. L., TANNENBAUM S. R., ROSS R. K., YU M. C., 2003. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Bio-markers Prev. 12, 503-507.
  • SOENGAS M., ALARCON R., YOSHIDA H., GIACCIA A. J., HAKEM R., MAK T. W., LOWE S. W., 1999. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156-159.
  • STELLER H., 1995. Mechanisms and genes of cellular suicide. Science 267, 1445-1449.
  • SULEJCZAK D., 2000. Apoptoza i metody jej identyfikacji. Post. Biol. Kom. 27, 527-568.
  • SUSIN S. A., LORENZO H. K., ZAMZAMI N., MARZO I., SNOW B. E., BROTHERS G. M., MANGION J., JACOTOT E., COSTATINI P., LOEFFLER M., LARPCHETTE N., GOODLETT D. R., AEBERSOLD R., SIDEROVSKI D., PENNINGER J. M., KROEMER G., 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446.
  • SZALA S., 2000. Swoista indukcja apoptozy w komórkach nowotworowych. Nowotwory 50, 111-121.
  • SZALA S., MITRUS I., MISSOL-KOLKA E., 2001. Geny proapoptotyczne w terapii genowej nowotworów. Współ. Onkol. 5, 242-249.
  • WANG Z., ZHANG Z., LIU Y., CHN Y., LI Q., DUANGULOAN, QIN D., LIU G., WANG L., 2000. Effect of retinoic acid and its complexes with transition metals on human bladder cancer cell line EJ in vitro.Urol. Res. 28, 191-195.
  • WADA Y., GOTOH A., SHIRAKAWA T., HAMADA K., KAMIDONO S., 2001 Gene therapy for bladder cancer using adenoviral vector. Mol. Urol. 2, 47-52.
  • WILLERT L., PERABO F., WIRGER A., SCHMIDT D., WARDELMANN E., RUECKER A., KOHN E., MUELLER S., 2002. Fas-ligand induced apoptosis of bladder cancer cells by staphylococcal enterotoxin B-mediated T-cell immune response ASCO Ann. Meeting. Abstract
  • YUAN S. Y., HSU S. L., TSAI K. J., YANG C. R., 2002. Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells. Urol. Res. 30, 282-288.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.